News
06-21-2016, 01:30 AM
An existing drug called denosumab has shown promise for the delay or prevention of breast cancer among women with a BRCA1 mutation.
More... (http://www.medicalnewstoday.com/articles/311096.php)
More... (http://www.medicalnewstoday.com/articles/311096.php)